Mao‐Song Tsai

850 citations
37 papers · 580 indexed · h-index 16
Topics
HIV/AIDS drug development and treatment (13 papers)HIV Research and Treatment (9 papers)Pneumocystis jirovecii pneumonia detection and treatment (8 papers)
Partner nations
TaiwanChinaSouth Korea

In The Last Decade

Mao‐Song Tsai

37 papers receiving 572 citations

Peers

Mao‐Song Tsai
Comparison fields: 5 of 72
  • Infectious Diseases 290
  • Epidemiology 266
  • Virology 117
  • Hepatology 109
  • Emergency Medicine 105
Replace Ryan Cooper with:
Ryan Cooper Canada
É. Rouveix France
Giovanni Cassola Italy
Daniel Grint United Kingdom
Shu‐Hsing Cheng Taiwan
A. Frésard France
Andrea Gabbuti Italy
Riccardo Raiteri Italy
Mallory D. Witt United States
Sebastian Noé Germany
Mao‐Song Tsai relative to Ryan Cooper Canada Ryan Cooper's profile →
Citations per field
00.5×1.5×2.0×
Ryan Cooper · 1×
Citations per year

Countries citing papers authored by Mao‐Song Tsai

Since Specialization
Citations

This map shows the geographic impact of Mao‐Song Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao‐Song Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao‐Song Tsai more than expected).

Fields of papers citing papers by Mao‐Song Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mao‐Song Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao‐Song Tsai. The network helps show where Mao‐Song Tsai may publish in the future.

Co-authorship network of co-authors of Mao‐Song Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Mao‐Song Tsai. A scholar is included among the top collaborators of Mao‐Song Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mao‐Song Tsai. Mao‐Song Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 11
3 5
4 14
5 14
6 19
7 18
8 10
9 15
10 14
11 6
12 35
13 15
14 6
15 10
16 12
17 4
18 24
19 19
20 18

About Mao‐Song Tsai

Mao‐Song Tsai is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 37 papers that have together received 580 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). The work is most often cited by research in Virology (117 citations), Infectious Diseases (290 citations) and Hepatology (109 citations). Mao‐Song Tsai has collaborated with scholars based in Taiwan, China and South Korea. Frequent co-authors include Chien‐Ching Hung, Hsin‐Yun Sun, Chia‐Jui Yang, Sui‐Yuan Chang, Wen‐Chun Liu, Shan‐Chwen Chang, Aristine Cheng, Pei‐Ying Wu, Yi‐Ching Su and Hung-Jen Tang. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026